CONTRI, CHIARA
 Distribuzione geografica
Continente #
AS - Asia 918
NA - Nord America 853
EU - Europa 544
SA - Sud America 189
AF - Africa 70
OC - Oceania 23
Totale 2.597
Nazione #
US - Stati Uniti d'America 798
SG - Singapore 305
IT - Italia 238
CN - Cina 160
BR - Brasile 125
VN - Vietnam 117
HK - Hong Kong 82
FR - Francia 67
GB - Regno Unito 55
DE - Germania 50
JP - Giappone 48
IN - India 37
CA - Canada 35
EG - Egitto 34
CO - Colombia 29
CH - Svizzera 21
NL - Olanda 20
ID - Indonesia 19
RU - Federazione Russa 18
AR - Argentina 17
ZA - Sudafrica 17
BD - Bangladesh 14
IR - Iran 14
MX - Messico 14
TR - Turchia 14
NZ - Nuova Zelanda 13
IL - Israele 12
IQ - Iraq 11
PK - Pakistan 11
AU - Australia 10
ES - Italia 10
KR - Corea 9
KZ - Kazakistan 9
BE - Belgio 8
IE - Irlanda 8
PH - Filippine 8
PL - Polonia 8
FI - Finlandia 7
SA - Arabia Saudita 7
TW - Taiwan 7
UZ - Uzbekistan 7
EC - Ecuador 6
MY - Malesia 6
AT - Austria 5
KE - Kenya 5
MA - Marocco 5
RS - Serbia 4
UA - Ucraina 4
GR - Grecia 3
JO - Giordania 3
KW - Kuwait 3
NG - Nigeria 3
PE - Perù 3
PS - Palestinian Territory 3
PY - Paraguay 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
PA - Panama 2
PT - Portogallo 2
RO - Romania 2
SE - Svezia 2
TH - Thailandia 2
VE - Venezuela 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
HU - Ungheria 1
JM - Giamaica 1
LK - Sri Lanka 1
LT - Lituania 1
MK - Macedonia 1
MT - Malta 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 2.597
Città #
Singapore 202
Ashburn 175
San Jose 98
Hong Kong 78
Beijing 49
Council Bluffs 40
Los Angeles 40
Santa Clara 37
Tokyo 36
Ho Chi Minh City 33
Cairo 29
Hanoi 28
Meridian 28
Albosaggia 24
Ferrara 21
Munich 20
New York 20
Jakarta 18
Lauterbourg 18
Bogotá 17
Milan 16
São Paulo 16
Naples 15
Shanghai 15
Denver 14
Zurich 14
Montreal 13
Chennai 12
Chandler 11
Hefei 11
Da Nang 10
Dallas 10
Rome 10
Toronto 10
Manchester 9
Orem 9
Tannowa 9
Tucson 9
Almaty 8
Brooklyn 8
Galway 8
Medellín 8
Ankara 7
Bologna 7
Buffalo 7
Johannesburg 7
Malonne 7
Warsaw 7
Campinas 6
Chicago 6
Haiphong 6
Livorno 6
Louisville 6
Tashkent 6
Atlanta 5
Azusa 5
Baghdad 5
Bari 5
Boston 5
Chattanooga 5
Christchurch 5
Dresden 5
Dunedin 5
Frankfurt am Main 5
Geneva 5
Madrid 5
Rio de Janeiro 5
Tel Aviv 5
Venice 5
Auburn 4
Curitiba 4
Falkenstein 4
London 4
Melbourne 4
Moscow 4
Nairobi 4
Nashville 4
Phoenix 4
Pisa 4
Poplar 4
Redondo Beach 4
Salt Lake City 4
San Diego 4
The Dalles 4
Vienna 4
Athens 3
Auckland 3
Belo Horizonte 3
Blumenau 3
Boardman 3
Brisbane 3
Bristol 3
Can Tho 3
Cuauhtémoc 3
Fairfield 3
Florence 3
Helsinki 3
Honolulu 3
Jammu 3
Jamnagar 3
Totale 1.518
Nome #
Pharmacological characterization of new modulators of the endocannabinoid system: from single target to multi-target compounds 733
Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target? 152
Adenosine and inflammation: Here, there and everywhere 148
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions 146
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets 137
Pharmacology of Adenosine Receptors: Recent Advancements 129
Pioneering first-in-class FAAH-HDAC inhibitors as potential multitarget neuroprotective agents 116
Synthesis of Unsymmetrical Squaramides as Allosteric GSK-3β Inhibitors Promoting β-Catenin-Mediated Transcription of TCF/LEF in Retinal Pigment Epithelial Cells 115
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies 114
Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence 113
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition 111
Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients 109
Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications 104
Cytotoxic and Antiproliferative Effects of [64Cu]CuCl2 in Tumor Cells for Radiometabolic Therapy: a Preliminary Study 104
Targeting Relevant HDACs to Support the Survival of Cone Photoreceptors in Inherited Retinal Diseases: Identification of a Potent Pharmacological Tool with In Vitro and In Vivo Efficacy 96
Cytotoxic and Antiproliferative Effects of [64Cu]CuCl2 in Tumor Cells for Radiometabolic Therapy: a Preliminary Study. 89
Uncovering a Mutation-Independent Therapeutic Strategy against Inherited Retinal Diseases: Development of Class I HDAC/LSD1 Hybrid Inhibitors 40
Cytotoxic and Antiproliferative Effects of [64Cu]CuCl2 in Tumor Cells for Radiometabolic Therapy 40
Reversing TGF-β1-induced fibrotic phenotype in human lung fibroblasts using a PROTAC tool derived from an indoline-based HDAC6 inhibitor 33
New Vanillyl-capped HDAC inhibitors exhibit anti-tumor efficacy in neuroblastoma and glioblastoma cells 30
Totale 2.659
Categoria #
all - tutte 9.402
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.402


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202218 0 0 0 0 0 0 0 7 0 0 8 3
2022/202331 3 5 0 3 2 3 6 2 3 0 3 1
2023/2024203 5 3 4 1 20 0 3 3 4 58 43 59
2024/2025752 42 52 53 39 58 74 49 53 111 68 82 71
2025/20261.655 180 72 153 178 254 127 179 136 159 217 0 0
Totale 2.659